2016
Discovery of Novel Haloalkane Dehalogenase Inhibitors
BURYŠKA, Tomáš, Lukáš DANIEL, Antonín KUNKA, Jan BREZOVSKÝ, Jiří DAMBORSKÝ et. al.Základní údaje
Originální název
Discovery of Novel Haloalkane Dehalogenase Inhibitors
Autoři
BURYŠKA, Tomáš (203 Česká republika, domácí), Lukáš DANIEL (203 Česká republika, domácí), Antonín KUNKA (203 Česká republika, domácí), Jan BREZOVSKÝ (203 Česká republika, domácí), Jiří DAMBORSKÝ (203 Česká republika, garant, domácí) a Zbyněk PROKOP (203 Česká republika, domácí)
Vydání
Applied and Environmental Microbiology, WASHINGTON, DC (USA), AMER SOC MICROBIOLOGY, 2016, 0099-2240
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10600 1.6 Biological sciences
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 3.807
Kód RIV
RIV/00216224:14310/16:00087944
Organizační jednotka
Přírodovědecká fakulta
UT WoS
000373339400032
Klíčová slova anglicky
SPHINGOMONAS-PAUCIMOBILIS UT26; AMBER FORCE-FIELD; MYCOBACTERIUM-TUBERCULOSIS; GENERALIZED BORN; SCORING FUNCTION; GAMMA-HEXACHLOROCYCLOHEXANE; BRADYRHIZOBIUM-JAPONICUM; CRYSTAL-STRUCTURE; PURIFICATION; SEQUENCE
Změněno: 3. 4. 2017 12:24, Ing. Andrea Mikešková
Anotace
V originále
Haloalkane dehalogenases (HLDs) have recently been discovered in a number of bacteria, including symbionts and pathogens of both plants and humans. However, the biological roles of HLDs in these organisms are unclear. The development of efficient HLD inhibitors serving as molecular probes to explore their function would represent an important step toward a better understanding of these interesting enzymes. Here we report the identification of inhibitors for this enzyme family using two different approaches. The first builds on the structures of the enzymes' known substrates and led to the discovery of less potent nonspecific HLD inhibitors. The second approach involved the virtual screening of 150,000 potential inhibitors against the crystal structure of an HLD from the human pathogen Mycobacterium tuberculosis H37Rv. The best inhibitor exhibited high specificity for the target structure, with an inhibition constant of 3 mu M and a molecular architecture that clearly differs from those of all known HLD substrates. The new inhibitors will be used to study the natural functions of HLDs in bacteria, to probe their mechanisms, and to achieve their stabilization.
Návaznosti
EE2.3.30.0037, projekt VaV |
| ||
GAP503/12/0572, projekt VaV |
| ||
LH14027, projekt VaV |
| ||
LO1214, projekt VaV |
|